![Hans Uno Postlind](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dr. Hans U.
Postlind is Vice President-Non Clinical Development at Karolinska Development AB. He is on the Board of Directors at KDev Exploratory AB, BioChromix Pharma AB, and ClanoTech AB.
| Companies | Position | End |
|---|---|---|
KDev Exploratory AB
 KDev Exploratory AB Miscellaneous Commercial ServicesCommercial Services Provides drug discovery solutions | Chairman | - |
ClanoTech AB
 ClanoTech AB Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cancer and macular degeneration | Director/Board Member | - |
| KDVENTURES AB | Corporate Officer/Principal | - |
BioChromix Pharma AB
 BioChromix Pharma AB Miscellaneous Commercial ServicesCommercial Services Provides Alzheimer disease research services | Director/Board Member | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 4 |
|---|---|
KDev Exploratory AB
KDev Exploratory AB Miscellaneous Commercial ServicesCommercial Services Provides drug discovery solutions | Commercial Services |
BioChromix Pharma AB
BioChromix Pharma AB Miscellaneous Commercial ServicesCommercial Services Provides Alzheimer disease research services | Commercial Services |
ClanoTech AB
ClanoTech AB Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cancer and macular degeneration | Health Technology |
Karolinska Development AB
 Karolinska Development AB Financial ConglomeratesFinance Operates as a life sciences investment company | Finance |
Select your edition
All financial news and data tailored to specific country editions
